Charney DS - Search Results

1

Long-term outcome of panic disorder after short-term imipramine and behavioral group treatment: 2.9-year naturalistic follow-up study.

Nagy LM, Krystal JH, Charney DS, Merikangas KR, Woods SW. Nagy LM, et al. Among authors: charney ds. J Clin Psychopharmacol. 1993 Feb;13(1):16-24. J Clin Psychopharmacol. 1993. PMID: 8098050

2

Open prospective trial of fluoxetine for posttraumatic stress disorder.

Nagy LM, Morgan CA 3rd, Southwick SM, Charney DS. Nagy LM, et al. Among authors: charney ds. J Clin Psychopharmacol. 1993 Apr;13(2):107-13. J Clin Psychopharmacol. 1993. PMID: 8463442

3

Naltrexone augmentation of neuroleptics in schizophrenia.

Sernyak MJ, Glazer WM, Heninger GR, Charney DS, Woods SW, Petrakis IL, Krystal JH, Price LH. Sernyak MJ, et al. Among authors: charney ds. J Clin Psychopharmacol. 1998 Jun;18(3):248-51. doi: 10.1097/00004714-199806000-00011. J Clin Psychopharmacol. 1998. PMID: 9617985 Clinical Trial.

4

Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine.

Krystal JH, McDougle CJ, Woods SW, Price LH, Heninger GR, Charney DS. Krystal JH, et al. Among authors: charney ds. Psychopharmacology (Berl). 1992;108(3):313-9. doi: 10.1007/BF02245117. Psychopharmacology (Berl). 1992. PMID: 1355923 Clinical Trial.

5

Controlled trial of alprazolam supplementation during imipramine treatment of panic disorder.

Woods SW, Nagy LM, Koleszar AS, Krystal JH, Heninger GR, Charney DS. Woods SW, et al. Among authors: charney ds. J Clin Psychopharmacol. 1992 Feb;12(1):32-8. doi: 10.1097/00001573-199202000-00006. J Clin Psychopharmacol. 1992. PMID: 1552038 Clinical Trial.

6

Characteristics of panic attack subtypes: assessment of spontaneous panic, situational panic, sleep panic, and limited symptom attacks.

Krystal JH, Woods SW, Hill CL, Charney DS. Krystal JH, et al. Among authors: charney ds. Compr Psychiatry. 1991 Nov-Dec;32(6):474-80. doi: 10.1016/0010-440x(91)90026-9. Compr Psychiatry. 1991. PMID: 1778074 Free article.

7

Behavioral, biochemical, and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in panic disorder.

Woods SW, Charney DS, Silver JM, Krystal JH, Heninger GR. Woods SW, et al. Among authors: charney ds. Psychiatry Res. 1991 Feb;36(2):115-27. doi: 10.1016/0165-1781(91)90124-8. Psychiatry Res. 1991. PMID: 1850142 Free article. Clinical Trial.

8

The effect of long-term imipramine treatment on carbon dioxide-induced anxiety in panic disorder patients.

Woods SW, Charney DS, Delgado PL, Heninger GR. Woods SW, et al. Among authors: charney ds. J Clin Psychiatry. 1990 Dec;51(12):505-7. J Clin Psychiatry. 1990. PMID: 2175307

9

Noradrenergic function in panic disorder.

Charney DS, Woods SW, Nagy LM, Southwick SM, Krystal JH, Heninger GR. Charney DS, et al. J Clin Psychiatry. 1990 Dec;51 Suppl A:5-11. J Clin Psychiatry. 1990. PMID: 2258377 Review.

10

Marijuana (cannabis) use is anecdotally said to precipitate anxiety symptoms in patients with panic disorder. Is there any research evidence to support this? Also, can marijuana use precipitate or expose paranoia in patients with an underlying bipolar disorder?

Seibyl JP, Krystal JH, Charney DS. Seibyl JP, et al. Among authors: charney ds. J Clin Psychopharmacol. 1990 Feb;10(1):78. doi: 10.1097/00004714-199002000-00033. J Clin Psychopharmacol. 1990. PMID: 2307743 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

631 results

Search Page